Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery isn’t an option? In the penultimate episode of the 2025 NSCLC Creator Weekend™ series, our multidisciplinary tumor board panel discusses the intricacies and decision-making processes surrounding biopsy and ablation procedures in thoracic oncology.
---
This podcast is supported by an educational grant from Johnson & Johnson and Varian.
---
SYNPOSIS
Topics include the prioritization of treatment versus tissue acquisition, the nuances of bronchoscopic versus percutaneous biopsies, and the latest advancements in robotic and cryo-biopsy techniques. The experts also share their approaches to managing pneumothorax, the value of multidisciplinary collaboration, and case studies that highlight personalized patient care. Listeners gain valuable insights into the evolving landscape of thoracic oncology procedures and the importance of patient-centered decision-making.
---
TIMESTAMPS
00:00 - Introduction
04:12 - Cryobiopy vs. Non-Cryobiopsy
08:43 - Biopsy and Ablation: Strategies and Considerations
15:31 - Post-Therapy Imaging and Follow-Up
25:18 - Treatment Options and Patient Decisions
27:08 - Evaluating Ablation Techniques
28:59 - Managing Lung Cancer Recurrence
39:41 - Case Study: Young Male with Ground Glass Nodule
43:15 - Concluding Thoughts
